VEGFA and non-small cell lung carcinoma: In non-small cell lung cancer models, atorvastatin was found to suppress Rac1/NADPH oxidase activity and reduction in vascular endothelial growth factor (VEGF) expression and ultimately inhibiting angiogenesis [59].